These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11486255)

  • 1. Preventing infectious disease in the domestic setting: a risk-based approach.
    Bloomfield SF
    Am J Infect Control; 2001 Aug; 29(4):207-10. PubMed ID: 11486255
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing a rational approach to hygiene in the domestic setting.
    Scott E
    J Infect; 2001 Jul; 43(1):45-9. PubMed ID: 11597159
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastrointestinal disease in the domestic setting: what are the issues?
    Bloomfield S
    J Infect; 2001 Jul; 43(1):23-9. PubMed ID: 11597154
    [No Abstract]   [Full Text] [Related]  

  • 4. Hygiene and health - the need for a holistic approach.
    Exner M; Hartemann P; Kistemann T
    Am J Infect Control; 2001 Aug; 29(4):228-31. PubMed ID: 11486260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing infectious intestinal disease in the domestic setting: a shared responsibility. Proceedings of a conference. December 6-7, 2000. London, United Kingdom.
    J Infect; 2001 Jul; 43(1):21-102. PubMed ID: 11597153
    [No Abstract]   [Full Text] [Related]  

  • 6. Using risk assessment, benefit-cost analysis, and real options to implement a precautionary principle.
    Farrow S
    Risk Anal; 2004 Jun; 24(3):727-35. PubMed ID: 15209941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of biocide usage and antimicrobial resistance in domiciliary environments.
    Bloomfield SF
    J Appl Microbiol; 2002; 92 Suppl():144S-57S. PubMed ID: 12000623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing MRSA infection in the community.
    Lautenbach E; Zaoutis T
    LDI Issue Brief; 2009 Aug; 14(6):1-4. PubMed ID: 19780236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of quantitative risk assessment for formulating hygiene policy in the domestic setting.
    Gerba CP
    J Infect; 2001 Jul; 43(1):92-8. PubMed ID: 11597169
    [No Abstract]   [Full Text] [Related]  

  • 10. Infectious disease prevention in the home and community: closing the circle.
    Bloomfield SF
    Perspect Public Health; 2015 Nov; 135(6):277-8. PubMed ID: 26543143
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of biocide usage and antimicrobial resistance in domiciliary environments.
    Bloomfield SF
    Symp Ser Soc Appl Microbiol; 2002; (31):144S-157S. PubMed ID: 12481839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a simple scoring tool in the primary care setting for prediction of recurrent falls in men and women aged 65 years and over living in the community.
    Woo J; Leung J; Wong S; Kwok T; Lee J; Lynn H
    J Clin Nurs; 2009 Apr; 18(7):1038-48. PubMed ID: 19207793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease risk analysis: A paradigm for using health-based data to inform primate conservation and public health.
    Jones-Engel L; Engel GA
    Am J Primatol; 2006 Sep; 68(9):851-4. PubMed ID: 16900505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polish forum for prevention guidelines on cardiovascular risk assessment].
    Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
    [No Abstract]   [Full Text] [Related]  

  • 16. Community-associated methicillin-resistant Staphylococcus aureus: review of an emerging public health concern.
    Drews TD; Temte JL; Fox BC
    WMJ; 2006 Jan; 105(1):52-7. PubMed ID: 16676492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing community-associated methicillin-resistant Staphylococcus aureus among student athletes.
    Many PS
    J Sch Nurs; 2008 Dec; 24(6):370-8. PubMed ID: 19114467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The new Protection against Infection Act].
    Niemer U
    Gesundheitswesen; 2001 Aug; 63 Suppl 2():S136-8. PubMed ID: 11533876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive approach to risk assessment and surveillance guiding public health interventions.
    Aagaard-Hansen J; Sørensen BH; Chaignat CL
    Trop Med Int Health; 2009 Sep; 14(9):1034-9. PubMed ID: 19552642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Apr; 99(7):1013-5. PubMed ID: 17398203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.